ELEVATION ONCOLOGY INC (ELEV) Stock Earnings & Estimates
NASDAQ:ELEV - US28623U1016 - Common Stock
0.365 USD
-0.01 (-2.12%)
0.377 USD
+0.01 (+3.29%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 290.98% | N/A -100.00% | N/A | N/A 362.07% | |||||||
| EBITDA YoY % growth | -5.88M | -17.26M -193.54% | -32.03M -85.57% | -94.52M -195.10% | -40.299M 57.36% | -44.679M -10.87% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.88M | -17.28M -193.88% | -32.05M -85.47% | -94.55M -195.01% | -40.338M 57.34% | -44.703M -10.82% | N/A 3.43% | N/A -14.63% | N/A -26.79% | N/A 9.11% | N/A -15.20% | N/A -14.04% | N/A 26.31% | N/A 139.96% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -4.09 -63.80% | -1.53 62.59% | -0.81 47.06% | N/A 7.71% | N/A 26.01% | N/A 15.17% | N/A 34.78% | N/A 140.00% | N/A 979.17% | N/A 89.58% | N/A 16.90% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.23 -27.22% | -0.14 36.95% | -0.14 21.94% | -0.16 32.85% | -0.27 -18.04% | -0.28 -98.53% | -0.27 -91.17% | -0.35 -115.19% | -0.35 -28.30% | -0.36 -29.63% |
| Revenue Q2Q % growth | N/A | N/A | N/A | |||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.462M -31.91% | -8.301M 37.25% | -8.453M 20.57% | -5.712M 47.31% | -19.788M -36.83% | -21.216M -155.58% | -21.165M -150.37% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.24 -4.35% | -0.20 | -0.04 | -22.07% |
| Q4 2024 Q2Q % growth | -0.18 5.26% | -0.23 | 0.05 | 20.91% |
| Q3 2024 Q2Q % growth | -0.22 12.00% | -0.20 | -0.02 | -8.46% |
| Q2 2024 Q2Q % growth | -0.18 51.35% | -0.23 | 0.05 | 21.12% |
| Q1 2024 Q2Q % growth | -0.23 68.06% | -0.21 | -0.02 | -11.52% |
| Q4 2023 Q2Q % growth | -0.19 76.83% | -0.24 | 0.05 | 21.54% |
| Q3 2023 Q2Q % growth | -0.25 85.03% | -0.33 | 0.08 | 23.41% |
| Q2 2023 Q2Q % growth | -0.37 56.98% | -0.33 | -0.04 | -12.77% |
| Q1 2023 Q2Q % growth | -0.72 2.70% | -0.60 | -0.12 | -19.30% |
| Q4 2022 Q2Q % growth | -0.82 -100.00% | -0.80 | -0.02 | -2.87% |
| Q3 2022 Q2Q % growth | -1.67 -215.09% | -1.32 | -0.35 | -26.14% |
| Q2 2022 Q2Q % growth | -0.86 82.23% | -0.80 | -0.06 | -7.03% |
| Q1 2022 Q2Q % growth | -0.74 | -0.51 | -0.23 | -44.00% |
| Q4 2021 Q2Q % growth | -0.41 | -0.60 | 0.19 | 31.41% |
| Q3 2021 Q2Q % growth | -0.53 | -0.39 | -0.14 | -35.40% |
| Q2 2021 Q2Q % growth | -4.84 | -2.88 | -1.96 | -68.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -29.48% | 0.44% | -10.92% |
| Revenue | N/A | N/A | N/A | N/A |